| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |